Search
Search Results
##search.searchResults.foundPlural##
-
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2991PDF: 1057HTML: 5644 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3882PDF: 1695HTML: 96 -
-
LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.
3801PDF: 1151HTML: 2476Figure 1: 229 -
-
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4601PDF: 1525HTML: 8539 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1593PDF: 935HTML: 386 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4358PDF: 1987HTML: 5520Table 1: 236 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1263PDF: 571HTML: 1711Figures: 192Fifures Sanz: 201tables Sanz: 206Untitled: 197 -
HEMATOPOIETIC STEM CELL TRNSPLANTATION IN THALASSEMIA AND RELATED DISORDERS
1958PDF: 508HTML: 4043 -
HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation
1338PDF: 893HTML: 267 -
THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA
2326PDF: 980HTML: 6860Figure 1: 201 -
-
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
856PDF: 569HTML: 4035 -
-
TYROSINE KINASE INHIBITORS AND INTERFERON
2958PDF: 1478HTML: 3099Cover Letter: 238 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
3201PDF: 1668HTML: 368 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4169PDF: 1202HTML: 2110Fig.1: 232Fig. 2: 127Table 1: 227Table2: 246Table 3: 226 -
ASSESSMENT OF THE EFFICACY OF PROCALCITONIN, C-REACTIVE PROTEIN AND ALBUMIN LEVELS-GUIDED ANTIBIOTICS USE IN SEPSIS
1025PDF: 606Html: 308Suppl. Files: 193 -
-
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3468PDF: 2047HTML: 7575 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1688PDF: 692HTML: 1449 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7888PDF: 2494HTML: 2121Table 1.: 251Table 2.: 261Table 3.: 243Table 4.: 238







